Clinical trial
Episodic Acyclovir Therapy for Genital Ulcers
NCT00164424 · Centers for Disease Control and Prevention, U.S. Fed · Completed
Key facts
| NCT number | NCT00164424 |
|---|---|
| Title | Episodic Acyclovir Therapy for Genital Ulcers |
| Official title | Impact of Episodic Acyclovir Therapy on Ulcer Duration and HIV Shedding From Genital Ulcers Among Men in South Africa |
| Lead sponsor | Centers for Disease Control and Prevention, U.S. Fed |
| Collaborators | London School of Hygiene and Tropical Medicine National Institute for Communicable Diseases, South Africa |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections, Ulcer, Herpes Simplex |
| Intervention type | Drug |
| Interventions | Acyclovir |
| Enrollment | 613 |
| Start date | Mar 1, 2005 |
| Primary completion | Mar 1, 2009 |
| Completion | Jul 1, 2011 |
| First posted | Sep 14, 2005 |
| Last update posted | Sep 11, 2012 |
| Countries | South Africa |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: